0001410939-22-000031.txt : 20220329 0001410939-22-000031.hdr.sgml : 20220329 20220329194400 ACCESSION NUMBER: 0001410939-22-000031 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220325 FILED AS OF DATE: 20220329 DATE AS OF CHANGE: 20220329 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SBLENDORIO GLENN CENTRAL INDEX KEY: 0001277478 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36080 FILM NUMBER: 22782746 MAIL ADDRESS: STREET 1: 3 TIMES SQAURE, 12TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IVERIC bio, Inc. CENTRAL INDEX KEY: 0001410939 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 208185347 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 8 SYLVAN WAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 BUSINESS PHONE: (609) 474-6755 MAIL ADDRESS: STREET 1: 8 SYLVAN WAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 FORMER COMPANY: FORMER CONFORMED NAME: Ophthotech Corp. DATE OF NAME CHANGE: 20070828 4 1 wf-form4_164859742561860.xml FORM 4 X0306 4 2022-03-25 0 0001410939 IVERIC bio, Inc. ISEE 0001277478 SBLENDORIO GLENN C/O IVERIC BIO, INC. 8 SYLVAN WAY PARSIPPANY NJ 07054 1 1 0 0 CEO Common Stock 2022-03-25 4 M 0 18775 2.94 A 298464 D Common Stock 2022-03-25 4 S 0 18775 17.06 D 279689 D Common Stock 0 I By trust for family member 1 Common Stock 0 I By trust for family member 2 Common Stock 0 I By trust for family member 3 Stock Option (right to buy) 2.94 2022-03-25 4 M 0 18775 0 D 2027-12-18 Common Stock 18775.0 368369 D The exercises and sales reported on this form were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 11, 2021, as previously disclosed in the Registrant's Quarterly Report on Form 10-Q for the quarter ended September 30, 2021, as filed with the Securities and Exchange Commission on November 9, 2021. The sale price of the Reporting Person's shares represents the weighted average price of all shares sold by a broker in multiple transactions effected at prices ranging from $17.00 to $17.28 per share on March 25, 2022. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Registrant or a security holder of the Registrant, information regarding the number of shares sold at each price within the range. On December 23, 2021, the Reporting Person gifted a total of 60,000 shares of Registrant's common stock to three trusts of which the Reporting Person's immediate family members are the sole trustees and sole beneficiaries. The Reporting Person reported these shares as indirectly owned following the gifts and disclaimed beneficial ownership. As of March 26, 2022, the Reporting Person no longer shares a primary residence with any of the trustees or beneficiaries of these trusts and no longer has a reportable beneficial interest in these shares. This stock option award was granted on December 19, 2017 and vested with respect to 25% of the shares subject to the option on the first anniversary of the grant date and with respect to the remaining shares in approximately equal monthly installments through the fourth anniversary of the grant date. /s/ Todd Anderman, as Attorney-in-Fact for Glenn P. Sblendorio 2022-03-29